Lower ghrelin levels does not impact the metabolic benefit induced by Roux-en-Y gastric bypass
ObjectiveRoux-en-Y gastric bypass is an effective intervention for metabolic disorder. We aim to elucidate whether ghrelin contributes to weight reduction, and glycemic and lipid control after Roux-en-Y gastric bypass (RYGB).DesignFour-week-old WT and Ghrl-TSC1-/- mice were fed high fat diet for 12...
| Published in: | Frontiers in Endocrinology |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.891379/full |
